Societe Generale analyst Justin Smith downgrades AbbVie (NYSE:ABBV) from Buy to Hold.
Societe Generale Downgrades AbbVie to Hold
Societe Generale analyst Justin Smith downgrades AbbVie (NYSE:ABBV) from Buy to Hold.
Related Posts
Warby Parker Q4 Sales $146.49M Beat $142.51M Estimate
Warby Parker (NYSE:WRBY) reported quarterly sales of $146.49 million which beat the analyst consensus estimate of $142.51 million by 2.79 percent. This is a 10.23 percent increase over sales of $132.89 million the same
Cadence Bank Announces Settlement Of Claims Made By U.S. Department Of Justice And The Office Of The Comptroller Of The Currency
Cadence Bancorporation (NYSE:CADE) (the "Company"), the parent company of Cadence Bank, N.A. (the "Bank"), announced today the Bank entered into separate settlements with the U.S. Department of
Applied Blockchain Q1 EPS $(0.04) Beats $(0.10) Estimate, Sales $6.90M Beat $6.64M Estimate
Applied Blockchain (NASDAQ:APLD) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.10) by 50 percent. The company reported quarterly sales of $6.90 million which beat the analyst consensus estimate of $6.64 million by 3.92 percent.